Kazem Rahimi, MD, discusses his recent IPD analysis highlighting the consistent relative risk reduction of first cardiovascular event with BP-lowering drugs.
Kazem Rahimi, MD
Advertisement
Kazem Rahimi, MD, is a professor of cardiovascular medicine and population health and the director of the Deep Medicine program at the University of Oxford.
Articles by Kazem Rahimi, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
The HCPFive: Top News for Healthcare Providers from the Week of 09/13
2
FDA Grants Priority Review for Insmed's ARIKAYCE sNDA for MAC Lung Disease
3
Half-Life vs. Real Life: How Real-World Evidence Is Reframing Wet AMD Treatment
4
When Innovation Builds Clinical Confidence: Evaluating Treatment Options in Hemophilia A
5